California device startup and women’s health firm Minerva Surgical has recently raised $20 million, according to a regulatory filing.
The Cupertino-based company has developed an endometrial ablation system utilizing RF Argon Plasma Energy contained in a balloon to treat heavy menstrual bleeding.
Based on a search of the U.S. Securities and Exchange Commission’s Edgar database, the company has been steadily raising money since 2008 and has raised more than $55 million. David M. Clapper, a 16-year veteran of Johnson & Johnson, is Minerva Surgical’s CEO.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Venture capital firm New Enterprise Associates and Vivo Ventures are investors in the company, although it is not known whether they invested in this round of funding.
[Photo Credit: Pile of Money from Big Stock Photo]
